ChitogenX Inc.
OTC: CHNXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pierre Laurin
- Employees
- 5
- Headquarters
- Kirkland, Canada
- IPO year
- 2020
- Market cap
- $627.6K
- Website
- https://www.chitogenx.com
Loading CHNXF…
Loading profile data…Frequently asked questions about CHNXF
What does ChitogenX Inc. (CHNXF) do?
ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development. Its developmental pipeline includes a range of specialize...
Where does CHNXF trade?
ChitogenX Inc. (CHNXF) trades on the Other OTC.
What sector is CHNXF in?
ChitogenX Inc. (CHNXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ChitogenX Inc.?
Pierre Laurin is the chief executive officer of ChitogenX Inc. (CHNXF).
Where is ChitogenX Inc. headquartered?
ChitogenX Inc. is headquartered in Canada.
Does CHNXF pay a dividend?
ChitogenX Inc. (CHNXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CHNXF go public?
ChitogenX Inc. (CHNXF) completed its initial public offering in 2020.